Exits

Enzyme

is FDA compliance as a service and was acquired by $ROIV.

View Company

Enzyme is a quality management system (QMS) software provider for life sciences companies, serving medical device, digital health, and biopharma organizations with a 21 CFR Part 11 compliant platform that supports the full product lifecycle from premarket to postmarket. The platform offers modules for document control, change control, design control, risk management, CAPA, and supplier management, and integrates with tools like Microsoft Office 365. In July 2025, Enzyme was acquired by Roivant.